ASAM Weekly for January 3, 2023

Detail

ASAM Weekly for January 3, 2023

by ASAM Weekly Editors

This Week in the ASAM Weekly

To borrow from a conceptualization about human behavior — a good way to predict future news is to look at past news. This week we present to you the most read news publications of 2022.

Well-recognized individuals — celebrities (Rolling Stone) and physicians alike (New Haven Register)— are hugely important for helping shift our understanding of addiction. Treatments that are considered game changers (LA Times; MSN) or changing the course of illness (MedPage) will equally gain our attention.

There is always space in the news cycle for the next emerging drug threat whether it’s a derivation of cannabis (NY Times), an animal tranquilizer (KHN), or one of the most commonly prescribed medications (UPI). In addition, a deeper appreciation for the human experience and drug use has taken hold in recent years (NY Times), helping shepherd greater acceptance towards the psychedelic medicine movement (NY Times).

Wishing the best to all our colleagues for 2023.

Thanks for reading,

Nicholas Athanasiou, MD, MBA, DFASAMEditor in Chiefwith Co-Editors: Brandon Aden, MD, Debra R. Newman, PA-C, MSPAS, MPH, Jack Woodside, MD, John A. Fromson, MD